Thu, April 1, 2021

Joseph Pantginis Maintained (ATNM) at Strong Buy with Decreased Target to $57 on, Apr 1st, 2021

Joseph Pantginis of HC Wainwright & Co., Maintained "Actinium Pharmaceuticals, Inc." (ATNM) at Strong Buy with Decreased Target from $65 to $57 on, Apr 1st, 2021.

Joseph, nor any peers, have made any analyst calls on ATNM in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30